查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604769

自動胰島素輸送系統市場：依疾病類型、分佈分類 - 2025-2030 年全球預測

Automated Insulin Delivery System Market by Disease Type (Type I Diabetes, Type II Diabetes), Distribution (Diabetes Clinics, Hospital Pharmacies, Retail Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年自動胰島素輸送系統市場規模預計為8.2139億美元，預計2024年將達到9.0104億美元，預計2030年複合年成長率為9.79%，達到15.7949億美元。

自動胰島素輸送系統 (AID) 市場作為一項透過自動化胰島素輸送來幫助糖尿病管理的技術正在不斷擴大。 AID 系統將連續血糖監測 (CGM) 與胰島素幫浦整合在一起，並採用先進的演算法來最佳化胰島素劑量。該系統透過減少手動血糖調節來改善第 1 型糖尿病患者和最近的 2 型糖尿病患者的生活品質至關重要。其使用主要擴展到個人使用，但診所的機構使用也在增加。關鍵的成長要素包括糖尿病盛行率上升、穿戴式醫療設備的技術進步以及醫療保健支出的增加。市場受益於人工智慧和機器學習的技術進步，為精準醫療的發展提供了新的途徑。這項創新可以增強治療計劃的個人化，並支持改善患者的長期結果。

主要市場統計
基準年[2023] 82139萬美元
預計年份 [2024] 90104萬美元
預測年份 [2030] 15.7949億美元
複合年成長率（%） 9.79%

新興市場存在著機遇，那裡的糖尿病患者數量正在迅速增加，這使得企業能夠開拓開拓的人群。此外，AID 系統與智慧型手機技術和物聯網平台的整合為增強遠端患者監護和遠端醫療服務提供了變革性機會。然而，開發中國家的高成本、監管障礙、網路安全問題以及對援助系統認知不足等挑戰正在阻礙成長。此外，由於保險覆蓋範圍有限以及缺乏訓練有素的專業人員來管理先進的糖尿病技術，市場面臨限制。

在創新方面，研發應重點關注改進即時資料分析演算法、提高穿戴式裝置的生物相容性以及開發具有成本效益的解決方案以供廣泛採用。公司可以投資研發策略聯盟，或探索基於訂閱的模式以提高可及性。市場洞察顯示了一個充滿活力和競爭的格局，其中創新、夥伴關係和監管環境是成功的關鍵。隨著技術的不斷發展，優先考慮以患者為中心的方法並投資於強大的網路安全措施的公司可能會擁有競爭優勢。

市場動態：揭示快速發展的自動胰島素輸送系統市場的關鍵市場洞察

供需的動態交互作用正在改變自動化胰島素輸送系統市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 糖尿病盛行率上升並加強宣傳宣傳活動
    • 改進的管道式和商用 AID 系統的可用性
    • 開發 AID 系統以改善臨床結果
  • 市場限制因素
    • 血糖感測器校準、感測器耐用性和皮膚相關問題
  • 市場機會
    • 升級現有胰島素幫浦並開發新產品
    • 增加研發活動以生產創新的胰島素輸送系統
  • 市場問題
    • 對泵浦不準確、感測器不準確和不可靠性的擔憂

波特五力：駕馭自動胰島素輸送系統市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解自動胰島素輸送系統市場的外部影響

外部宏觀環境因素在塑造自動胰島素輸送系統市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解自動化胰島素輸送系統市場的競爭格局

自動胰島素輸送系統市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：自動胰島素輸送系統市場供應商的績效評估

FPNV 定位矩陣是評估自動胰島素輸送系統市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：制定自動胰島素輸送系統市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，自動胰島素輸送系統市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 糖尿病盛行率上升並加強宣傳宣傳活動
      • 改進商業 AID 系統的管道和可用性
      • 開發可改善臨床結果的 AID 系統
    • 抑制因素
      • 血糖感測器校準、感測器耐用性和皮膚相關問題
    • 機會
      • 升級現有胰島素幫浦並開發新產品
      • 加強研發活動以生產創新的胰島素輸送系統
    • 任務
      • 對泵浦不準確和感測器不準確和不可靠性的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 自動胰島素輸送系統市場：依疾病類型

  • 介紹
  • 1型糖尿病
  • 2型糖尿病

第7章 自動胰島素輸送系統市場：依分佈

  • 介紹
  • 糖尿病診所
  • 醫院藥房
  • 零售藥房

第8章美洲自動胰島素輸送系統市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太自動胰島素輸送系統市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲/中東/非洲自動胰島素輸送系統市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Animas Corporation
  • Becton, Dickinson and Company
  • Bigfoot Biomedical Inc.
  • Biocon Limited
  • Dexcom, Inc.
  • Diabeloop SA
  • DreaMed Diabetes Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Medtronic PLC
  • Novo Nordisk A/S
  • Sanofi SA
  • Tandem Diabetes Care, Inc.
Product Code: MRR-437517DB6E7D

The Automated Insulin Delivery System Market was valued at USD 821.39 million in 2023, expected to reach USD 901.04 million in 2024, and is projected to grow at a CAGR of 9.79%, to USD 1,579.49 million by 2030.

The market for Automated Insulin Delivery Systems (AID) is expanding as technology aids diabetes management by automating insulin delivery. The AID system integrates continuous glucose monitoring (CGM) with insulin pumps and advanced algorithms to optimize insulin dosage. This system is crucial for enhancing the quality of life for individuals with Type 1 and increasingly, Type 2 diabetes, by mitigating manual blood glucose regulation. Its application spans personal use predominantly, but institutional use in clinics is gaining traction. Key growth factors include rising diabetes prevalence, technological advancements in wearable medical devices, and increased healthcare expenditure. The market benefits significantly from technological progress in AI and machine learning, offering novel avenues for precision medicine development. This innovation can bolster personalization in treatment plans, supporting better long-term patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 821.39 million
Estimated Year [2024] USD 901.04 million
Forecast Year [2030] USD 1,579.49 million
CAGR (%) 9.79%

Opportunities lie in emerging markets where diabetes incidences are surging, allowing companies to tap into untapped demographics. Additionally, the integration of AID systems with smartphone technology and IoT platforms represents a transformative opportunity, as it enhances remote patient monitoring and telehealth services. However, challenges such as high cost, regulatory hurdles, cybersecurity concerns, and inadequate awareness about AID systems in developing nations impede growth. Furthermore, the market faces limitations due to restricted insurance coverage and a lack of trained professionals to manage sophisticated diabetes tech.

For innovation, research should focus on enhancing algorithm sophistication for real-time data analytics, improving biocompatibility of wearable devices, and developing cost-effective solutions to widen adoption. Businesses could invest in strategic collaborations for R&D or explore subscription-based models to enhance accessibility. Insight into the market suggests a dynamic and competitive landscape where innovation, partnerships, and regulatory navigation are key to success. As technology continues to evolve, businesses that prioritize patient-centric approaches and invest in robust cybersecurity measures will likely hold a competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Automated Insulin Delivery System Market

The Automated Insulin Delivery System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of diabetes coupled with increasing number of awareness campaigns
    • Availability of improved pipelined and marketed AID systems
    • Developments in AID systems with improved clinical outcomes
  • Market Restraints
    • Calibration of a glucose sensor, sensor durability, skin-related issues
  • Market Opportunities
    • Up-gradation of existing insulin pumps and new product developmen
    • Increasing R&D activities for the production of innovative insulin delivery systems
  • Market Challenges
    • Concerns regarding pump imprecision and sensor inaccuracy or unreliability

Porter's Five Forces: A Strategic Tool for Navigating the Automated Insulin Delivery System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Automated Insulin Delivery System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Automated Insulin Delivery System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Automated Insulin Delivery System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Automated Insulin Delivery System Market

A detailed market share analysis in the Automated Insulin Delivery System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Automated Insulin Delivery System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Automated Insulin Delivery System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Automated Insulin Delivery System Market

A strategic analysis of the Automated Insulin Delivery System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Automated Insulin Delivery System Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Animas Corporation, Becton, Dickinson and Company, Bigfoot Biomedical Inc., Biocon Limited, Dexcom, Inc., Diabeloop S.A., DreaMed Diabetes Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Insulet Corporation, Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., and Tandem Diabetes Care, Inc..

Market Segmentation & Coverage

This research report categorizes the Automated Insulin Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Type, market is studied across Type I Diabetes and Type II Diabetes.
  • Based on Distribution, market is studied across Diabetes Clinics, Hospital Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of diabetes coupled with increasing number of awareness campaigns
      • 5.1.1.2. Availability of improved pipelined and marketed AID systems
      • 5.1.1.3. Developments in AID systems with improved clinical outcomes
    • 5.1.2. Restraints
      • 5.1.2.1. Calibration of a glucose sensor, sensor durability, skin-related issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Up-gradation of existing insulin pumps and new product developmen
      • 5.1.3.2. Increasing R&D activities for the production of innovative insulin delivery systems
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding pump imprecision and sensor inaccuracy or unreliability
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Automated Insulin Delivery System Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Type I Diabetes
  • 6.3. Type II Diabetes

7. Automated Insulin Delivery System Market, by Distribution

  • 7.1. Introduction
  • 7.2. Diabetes Clinics
  • 7.3. Hospital Pharmacies
  • 7.4. Retail Pharmacies

8. Americas Automated Insulin Delivery System Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Automated Insulin Delivery System Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Automated Insulin Delivery System Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Animas Corporation
  • 3. Becton, Dickinson and Company
  • 4. Bigfoot Biomedical Inc.
  • 5. Biocon Limited
  • 6. Dexcom, Inc.
  • 7. Diabeloop S.A.
  • 8. DreaMed Diabetes Ltd.
  • 9. Eli Lilly and Company
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Insulet Corporation
  • 12. Medtronic PLC
  • 13. Novo Nordisk A/S
  • 14. Sanofi S.A.
  • 15. Tandem Diabetes Care, Inc.

LIST OF FIGURES

  • FIGURE 1. AUTOMATED INSULIN DELIVERY SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. AUTOMATED INSULIN DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AUTOMATED INSULIN DELIVERY SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE I DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE II DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 100. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. AUTOMATED INSULIN DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023